Get ready for $178 billion of selling ahead of the capital-gains tax hike. These are the stocks most at risk.

In any case, the stock market reacted negatively to the Bloomberg News report that the White House was considering doubling capital-gains taxes on the wealthy to help pay for social spending, as the S&P 500 SPX, -0.92% dropped by the most in a month. The news was particularly jarring to the highflying cryptocurrency space, with bitcoin BTCUSD, -3.89% and ethereum ETHUSD, -5.10% slumping.

One question now is whether the closely divided Senate will go for it. “Frankly, I suspect that these proposed tax increases will be knocked down at the hands of Senator [Joe] Manchin who remains the ‘swing’ vote in the Senate,” said Louis Navellier, the chairman of Navellier & Associates. An alternative is that the Senate could increase the capital-gains tax, but by a smaller amount — analysts at Goldman Sachs suggest they’ll settle at 28%, up from 20% currently. Another question is whether the tax will be applied retroactively or not.

Analysts at Goldman Sachs — in October — ran the numbers on the stock market impact of previous capital-gains tax hikes. While there is only a modest impact on the stock market as a whole, momentum stocks usually get socked before they are levied, they found. That makes sense — investors logically are more motivated to sell the stocks where they would save the most by avoiding higher capital-gains taxes.

The last time capital-gains taxes were hiked, in 2013, the wealthiest households sold 1% of their equity assets, the Goldman analysts found. According to the Federal Reserve’s distributional financial account data, the top 1% held $17.79 trillion of equities and mutual funds in the fourth quarter of 2020 — so a 1% selling of stocks this time would be $178 billion. (The most recent Internal Revenue Service breakdown, from 2018, found that millionaires accounted for just over 500,000 filers, or about 0.4% of the total.)

Here is the list of the top price gainers in the S&P 500 and Nasdaq-100 over the last year and over the last five years.

Intel and Mattel beat expectations

There were a few notable earnings released on Thursday night. Microchip maker Intel INTC, -1.77% easily beat earnings expectations and lifted its revenue guidance for the year, though investors focused on the declining revenue from the unit that produces chips for data centers. Toy maker Mattel MAT, +0.14% reported a smaller-than-forecast loss, as sales trounced estimates. Social-media service Snap SNAP, -2.14% broke even on better-than-expected revenue.

A Food and Drug Administration committee may recommend resuming the use of pharmaceutical Johnson & Johnson’s JNJ, -0.85% COVID-19 vaccine with a blood-clot warning, as European regulators have done. A Politico report said the White House has now largely written off the J&J shot, not just because of the blood-clot issue but also contamination issues.

The flash purchasing managers indexes and new home sales report highlight the economic releases. The eurozone flash PMI beat expectations, with the services component rising above the 50 mark indicating expansion for the first time since August.

Stock futures higher

U.S. stock futures ES00, +0.21% NQ00, +0.16% edged up after the sharp decline on Thursday. The yield on the 10-year Treasury BX:TMUBMUSD10Y was 1.55%.

Random reads

The launch of crew to the International Space Station was successful on Friday morning — here’s a profile of the four astronauts on board.

The Los Angeles Dodgers will set aside a “vaccinated only” section for Saturday’s baseball game.

A man used 80 pounds of explosives — for a gender-reveal party.

Need to Know starts early and is updated until the opening bell, but sign up here to get it delivered once to your email box. The emailed version will be sent out at about 7:30 a.m. Eastern.

Want more for the day ahead? Sign up for The Barron’s Daily, a morning briefing for investors, including exclusive commentary from Barron’s and MarketWatch writers.